eScreen, based in Overland Park, KS, deploys a well-regarded automated platform and FDA-authorized reader for the gathering, handling and reporting of non-regulated and regulated urine drug screens.

Through eScreen, deverus, Inc. can now offer its clients a paperless solution to collection facilities. AUSTIN, Texas – Jan. 4 (SEND2PRESS NEWSWIRE) — deverus, Inc., the leader in background screening ...

Salt Lake City, UT, April 21, 2010 --(PR.com)-- TazWorks LLC, a web-based background screening software company announces completion of technical details for integration with eScreen, a ...

Global private equity firm The Carlyle Group today announced it has made an investment in eScreen, Inc., a leading provider of instrumented drug screening and electronic hiring program management ...

Publicly traded Alere Inc. is paying up to $340 million to buy eScreen Inc., a technology company that specializes in toxicology screening and employee health products and services. The purchase price ...

Law360, New York (February 28, 2012, 1:27 PM EST) -- Health management company Alere Inc. has agreed to purchase toxicology screening company eScreen Inc. for $270 million in a move to strengthen its ...

Medical diagnostics company Alere has entered into an agreement to buy eScreen, Inc., a technology firm that specializes in toxicology screening and employee health products and services, for up to ...

New eScreen eCup+ Drug Testing are available at Lane Regional Medical Center and FASTLane After Hours Urgent Care. Lane has expanded its occupational medicine services by adding eScreen eCup+, which ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. General Manager Chris Tarpey details eScreen’s growth and ...

Health-care products company Alere Inc. said it will acquire eScreen Inc. for $270 million in a deal that will expand the company's presence in the global toxicology market. EScreen specializes in ...